Modification of morphine analgesia by venlafaxine in diabetic neuropathic pain model

Pharmacological Reports

Volumn 64, Issue 5, 2012, Pages 1267-1275

  Cegielska Perun, Krystyna ^a   Bujalska Zadrozny, Magdalena ^a   Makulska Nowak, Helena E ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Morphine; Neuropathic pain; Rats; Venlafaxine

Indexed keywords

MORPHINE; STREPTOZOCIN; VENLAFAXINE;

ACUTE DRUG ADMINISTRATION; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENTIATION; HYPERALGESIA; MALE; MECHANICAL STIMULATION; NONHUMAN; PAIN THRESHOLD; RAT; SINGLE DRUG DOSE; STREPTOZOCIN DIABETES; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 84873707171     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(12)70923-4     Document Type: Article

References (29)

1. Aley KO, Levine JD: Different peripheral mechanisms mediate enhanced nociception in metabolic/toxic and traumatic painful peripheral neuropathies in the rat. Neuroscience, 2002, 111, 389-397. (Pubitemid 34449699)
2. Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, Nurmikko T: European Federation of Neurological Societies: EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol, 2010, 17, 1113-1188.
3. Benbouzid M, Choucair-Jaafar N, Yalcin I, Waltisperger E, Muller A, Freund-Mercier MJ, Barrot M: Chronic, but not acute, tricyclic antidepressant treatment alleviates neuropathic allodynia after sciatic nerve cuffing in mice. Eur J Pain, 2008, 12, 1008-1017.
4. Bujalska M, Malinowska E, Makulska-Nowak H, Gumułka SW: Magnesium ions and opioid agonist activity in streptozotocin-induced hyperalgesia. Pharmacology, 2008, 82, 180-186.
5. Courteix C, Bardin M, Chantelauze C, Lavarenne J, Eschalier A: Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesics. Pain, 1994, 57, 153-160. (Pubitemid 24168732)
6. Courteix C, Eschalier A, Lavarenne J: Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain, 1993, 53, 81-88. (Pubitemid 23137271)
7. Godefroy F, Butler SH, Weil-Fugazza J, Besson JM: Do acute or chronic tricyclic antidepressants modify morphine antinociception in arthritic rats? Pain, 1986, 25, 233-244. (Pubitemid 16121649)
8. Gutiérrez M, Ortega-Alvaro A, Gibert-Rahola J, Micó JA: Interactions of acute morphine with chronic imipramine and fluvoxamine treatment on the antinociceptive effect in arthritic rats. Neurosci Lett, 2003, 352, 37-40.
9. Hasegawa Y, Kishimoto S, Shibatani N, Nomura H, Ishii Y, Onishi M, Inotsume N et al.: The pharmacokinetics of morphine and its glucuronide conjugate in a rat model of streptozotocin-induced diabetes and the expression of MRP2, MRP3 and UGT2B1 in the liver. J Pharm Pharmacol, 2010, 62, 310-314.
10. Hoybergs YM, Meert TF: The effect of low-dose insulin on mechanical sensitivity and allodynia in type I diabetes neuropathy. Neurosci Lett, 2007, 417, 149-154. (Pubitemid 46551356)
11. Juś A, Bujalska M, Makulska-Nowak HE: Modification of fentanyl analgesia by antidepressants. Pharmacology, 2010, 85, 48-53.
12. Kellstein DE, Malseed RT, Ossipov MH, Goldstein FJ: Effect of chronic treatment with tricyclic antidepressants upon antinociception induced by intrathecal injection of morphine and monoamines. Neuropharmacology, 1988, 27, 1-14. (Pubitemid 18011712)
13. Marchand F, Alloui A, Chapuy E, Hernandez A, Pelissier T, Ardid D, Eschalier A: The antihyperalgesic effect of venlafaxine in diabetic rats does not involve the opioid system. Neurosci Lett, 2003, 342, 105-108. (Pubitemid 36513920)
14. Marchand F, Alloui A, Chapuy E, Jourdan D, Pelissier T, Ardid D, Hernandez A et al.: Evidence of a monoamine mediated, opioid-independent, antihyperalgesic effect of venlafaxine, a non-tricyclic antidepressant, in a neurogenic pain model in rats. Pain, 2003, 103, 229-235. (Pubitemid 36638812)
15. Marchand F, Alloui A, Pelissier T, Hernández A, Authier N, Alvarez P, Eschalier A et al.: Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat. Brain Res, 2003, 980, 117-120. (Pubitemid 36836119)
16. Nakhoda A, Wong HA: The induction of diabetes in rats by intramuscular administration of streptozotocin. Experientia, 1979, 35, 1679-1680. (Pubitemid 10157002)
17. Onal A, Parlar A, Ulker S: Milnacipran attenuates hyperalgesia and potentiates antihyperalgesic effect of tramadol in rats with mononeuropathic pain. Pharmacol Biochem Behav, 2007, 88, 171-178. (Pubitemid 350116001)
18. Pakulska W: Influence of sertraline on the antinociceptive effect of morphine, metamizol and indomethacin in mice. Acta Pol Pharm Drug Res, 2004, 61, 157-163.
19. Przeklasa-Muszyńska A, Dobrogowski J: Transdermal buprenorphine in the treatment of cancer and non-cancer pain - the results of multicenter studies in Poland. Pharmacol Rep, 2011, 63, 935-948.
20. Reisine T, Soubrie P: Loss of rat cerebral cortical opiate receptors following chronic desimipramine treatment. Eur J Pharmacol, 1982, 77, 39-44. (Pubitemid 12209727)
21. Rosland JH, Hunskaar S, Hole K: Modification of the antinociceptive effect of morphine by acute and chronic administration of clomipramine in mice. Pain, 1988, 33, 349-355.
22. Sigaudo-Roussel D, Fromy B, Saumet JL: Diabetic neuropathy in animal models. Drug Discov Today Dis Models, 2007, 4, 39-44. (Pubitemid 350286529)
23. Smith HS, Afgoff CE: Pharmacological treatment of diabetic neuropathic pain. Drugs, 2011, 71, 557-589.
24. Sounvoravong S, Nakashima MN, Wada M, Nakashima K: Modification of antiallodynic and antinociceptive effects of morphine by peripheral and central action of fluoxetine in a neuropathic mice model. Acta Biol Hung, 2007, 58, 369-379. (Pubitemid 351160511)
25. Stengaard-Pedersen K, Schou M: Opioid receptors in the brain of the rat following chronic treatment with desipramine and electroconvulsive shock. Neuropharmacology, 1986, 25, 1365-1371. (Pubitemid 17215173)
26. Uyar M, Onal A, Uyar M, Dogru A, Soykan N: The antinociceptive effect of tramadol-venlafaxine combination on the paw withdrawal threshold in a rat model of neuropathic pain. Methods Find Exp Clin Pharmacol, 2003, 25, 361-365. (Pubitemid 36869901)
27. Wattiez AS, Libert F, Privat AM, Loiodice S, Fialip J, Eschalier A, Courteix C: Evidence for a differential opioidergic involvement in the analgesic effect of antidepressants: prediction for efficacy in animal models of neuropathic pain? Br J Pharmacol, 2011, 163, 792-803.
28. Wrzosek A, Obara I, Wordliczek J, Przewlocka B: Efficacy of tramadol in combination with doxepin or venlafaxine in inhibition of nociceptive process in the rat model of neuropathic pain: an isobolographic analysis. J Physiol Pharmacol, 2009, 60, 71-78.
29. Yee-Chi L, Phoon-Ping Ch: A review of SSRIs and SNRIs in neuropathic pain. Expert Opin. Pharmacother, 2010, 11, 2813-2815.